Cargando…
RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response
BACKGROUND: Challenges around the design and investigation of cell culture models of adamantinomatous craniopharyngioma (ACP) have arisen from the cellular heterogeneity of these tumors, with populations that harbor disparate requirements in culture. Novel approaches to in vitro modeling of ACP are...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165211/ http://dx.doi.org/10.1093/neuonc/noac079.049 |
_version_ | 1784720337898831872 |
---|---|
author | Trudeau, Tammy Prince, Eric Chatain, Oscar Chee, Keanu Jackson, Eric Limbrick, David Naftel, Robert Feldstein, Neil Grant, Gerald Ginn, Kevin Niazi, Toba Smith, Amy Kilburn, Lindsay Chern, Joshua Drapeau, Annie Lam, Sandi Johnston, James Dudley, Roy Staulcup, Susan Hankinson, Todd |
author_facet | Trudeau, Tammy Prince, Eric Chatain, Oscar Chee, Keanu Jackson, Eric Limbrick, David Naftel, Robert Feldstein, Neil Grant, Gerald Ginn, Kevin Niazi, Toba Smith, Amy Kilburn, Lindsay Chern, Joshua Drapeau, Annie Lam, Sandi Johnston, James Dudley, Roy Staulcup, Susan Hankinson, Todd |
author_sort | Trudeau, Tammy |
collection | PubMed |
description | BACKGROUND: Challenges around the design and investigation of cell culture models of adamantinomatous craniopharyngioma (ACP) have arisen from the cellular heterogeneity of these tumors, with populations that harbor disparate requirements in culture. Novel approaches to in vitro modeling of ACP are needed. METHODS: Intraoperatively collected tumor specimens were mechanically digested and plated under conditions tailored to the cell population of interest. ACP tumor-derived fibroblasts and epithelial cells were isolated using serum-containing and keratinocyte-specific media respectively. ACP-derived epithelial cells were immortalized via SV40 virus transfection and puromycin treatment for stable cell-line generation. Cell line validation included immunofluorescence with markers appropriate for the cell population of interest. RNA sequencing of cell lines was compared to ACP transcriptome reference data. Cell typing was conducted using short tandem repeat sequencing. RESULTS: ACP fibroblasts and ACP epithelial cells maintained spindle-like and cobblestone morphologies respectively, even after 4 passages. Immunofluorescence staining confirmed high levels of Vimentin expression in ACP-derived fibroblasts, and panCK and B-catenin in ACP-derived epithelial cells. Point mutation in exon 3 of the CTNNB1 gene was identified in ACP-derived epithelial cells. CONCLUSION: Initial limits related to cell line development in ACP may be addressed through the isolation and culture-specific ACP cell populations. This experience demonstrates the maintenance of validated markers of the cell populations of interest ex vivo. While preliminary, such cell lines offer promise as tools for the identification and study of potential therapeutic vulnerabilities in ACP. |
format | Online Article Text |
id | pubmed-9165211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91652112022-06-05 RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response Trudeau, Tammy Prince, Eric Chatain, Oscar Chee, Keanu Jackson, Eric Limbrick, David Naftel, Robert Feldstein, Neil Grant, Gerald Ginn, Kevin Niazi, Toba Smith, Amy Kilburn, Lindsay Chern, Joshua Drapeau, Annie Lam, Sandi Johnston, James Dudley, Roy Staulcup, Susan Hankinson, Todd Neuro Oncol Craniopharyngioma and Rare Tumors BACKGROUND: Challenges around the design and investigation of cell culture models of adamantinomatous craniopharyngioma (ACP) have arisen from the cellular heterogeneity of these tumors, with populations that harbor disparate requirements in culture. Novel approaches to in vitro modeling of ACP are needed. METHODS: Intraoperatively collected tumor specimens were mechanically digested and plated under conditions tailored to the cell population of interest. ACP tumor-derived fibroblasts and epithelial cells were isolated using serum-containing and keratinocyte-specific media respectively. ACP-derived epithelial cells were immortalized via SV40 virus transfection and puromycin treatment for stable cell-line generation. Cell line validation included immunofluorescence with markers appropriate for the cell population of interest. RNA sequencing of cell lines was compared to ACP transcriptome reference data. Cell typing was conducted using short tandem repeat sequencing. RESULTS: ACP fibroblasts and ACP epithelial cells maintained spindle-like and cobblestone morphologies respectively, even after 4 passages. Immunofluorescence staining confirmed high levels of Vimentin expression in ACP-derived fibroblasts, and panCK and B-catenin in ACP-derived epithelial cells. Point mutation in exon 3 of the CTNNB1 gene was identified in ACP-derived epithelial cells. CONCLUSION: Initial limits related to cell line development in ACP may be addressed through the isolation and culture-specific ACP cell populations. This experience demonstrates the maintenance of validated markers of the cell populations of interest ex vivo. While preliminary, such cell lines offer promise as tools for the identification and study of potential therapeutic vulnerabilities in ACP. Oxford University Press 2022-06-03 /pmc/articles/PMC9165211/ http://dx.doi.org/10.1093/neuonc/noac079.049 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Craniopharyngioma and Rare Tumors Trudeau, Tammy Prince, Eric Chatain, Oscar Chee, Keanu Jackson, Eric Limbrick, David Naftel, Robert Feldstein, Neil Grant, Gerald Ginn, Kevin Niazi, Toba Smith, Amy Kilburn, Lindsay Chern, Joshua Drapeau, Annie Lam, Sandi Johnston, James Dudley, Roy Staulcup, Susan Hankinson, Todd RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response |
title | RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response |
title_full | RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response |
title_fullStr | RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response |
title_full_unstemmed | RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response |
title_short | RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response |
title_sort | rare-24. the use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response |
topic | Craniopharyngioma and Rare Tumors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165211/ http://dx.doi.org/10.1093/neuonc/noac079.049 |
work_keys_str_mv | AT trudeautammy rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse AT princeeric rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse AT chatainoscar rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse AT cheekeanu rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse AT jacksoneric rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse AT limbrickdavid rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse AT naftelrobert rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse AT feldsteinneil rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse AT grantgerald rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse AT ginnkevin rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse AT niazitoba rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse AT smithamy rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse AT kilburnlindsay rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse AT chernjoshua rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse AT drapeauannie rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse AT lamsandi rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse AT johnstonjames rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse AT dudleyroy rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse AT staulcupsusan rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse AT hankinsontodd rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse |